Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 217
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #233: FDA Floats Ibogaine Trial Design; Compass Talks Pricing; Potential LSD, Psilocybin Brand Names
Kenneth Tupper, PhD: Harm Reduction, Drug Education, Canadian Ayahuasca, and Psychedelic Public Health
Weekly Psychedelic Policy Briefing: October 5, 2026
Podcast: Oregon Backtracks on Fee Hike, California Funds Psychedelic Research, DEA Moves to Schedule 5 Tryptamines
Psychedelic Churches Need Psychedelic Seminaries
Entheon Biomedical Provides Update on DMT Human Trial and Announces Regulatory...
Field Trip Announces Intention to Make Applications on Behalf of Patients...
PharmaTher Announces Publication of Research Data for KETABET™
Filament Health Announces Health Canada Approval for Phase II Trial Administering...
Psychedelic Drug Policy Reform in 2021
Psychedelics 2021: A Year in Review
The McQuade Center for Strategic Research and Development and Mindset Pharma...
Awakn Life Sciences Announces Voluntary Lock-up Agreement Extension with Management, Board...
PT281 – Oliver Grundmann, Ph.D. – A Thorough Exploration of Kratom
MindMed Successfully Completes Phase 1 Clinical Trial of 18-MC
Load more